IACUC Veterinarians As Intermediaries

As a diplomate of the American College of Laboratory Animal Medicine for the past 31 years, and an institutional animal care and use committee (IACUC) veterinarian on the committees of two institutions, I must take serious exception to your statement that "these IACUC veterinarians have the power to approve, disapprove, or demand significant change in experimental design and conduct" (R. Finn, The Scientist, May 26, 1997, page 1). I call your attention to the Public Health Policy on Humane Car

Written byEdward Greenstein
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As a diplomate of the American College of Laboratory Animal Medicine for the past 31 years, and an institutional animal care and use committee (IACUC) veterinarian on the committees of two institutions, I must take serious exception to your statement that "these IACUC veterinarians have the power to approve, disapprove, or demand significant change in experimental design and conduct" (R. Finn, The Scientist, May 26, 1997, page 1).

I call your attention to the Public Health Policy on Humane Care and Use of Laboratory Animals, Section IV B, "Functions of the Institutional Animal Care and Use Committee," pages 7-8, and 9CFR Ch.1, 2.31 Animal Plant Health Inspection Service, a United States Department of Agriculture document also known as the Animal Welfare Act. The powers you delegate to the IACUC vet are in fact the powers of the IACUC as a whole, whose members include: one DVM, one practicing scientist, one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies